Hutchin Hill Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,581
Closed -$497K 886
2017
Q1
$497K Buy
+14,581
New +$479K 0.01% 659
2016
Q4
Sell
-53,674
Closed -$1.73M 730
2016
Q3
$1.73M Buy
53,674
+13,450
+33% +$436K 0.04% 257
2016
Q2
$1.24M Buy
+40,224
New +$1.26M 0.04% 272
2016
Q1
Sell
-145,561
Closed -$4.03M 663
2015
Q4
$4.03M Buy
+145,561
New +$4.14M 0.1% 190
2015
Q1
Sell
-23,129
Closed -$708K 698
2014
Q4
$708K Sell
23,129
-6,411
-22% -$200K 0.03% 397
2014
Q3
$867K Buy
+29,540
New +$900K 0.03% 392
2013
Q4
Sell
-22,752
Closed -$624K 551
2013
Q3
$624K Sell
22,752
-3,142
-12% -$80.7K 0.06% 281
2013
Q2
$593K Buy
+25,894
New +$585K 0.06% 274

Other funds holding EHC

Hutchin Hill Capital's EHC Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Encompass Health (EHC) in Q2 2017, closing a stake of 14,581 shares — an estimated $497K sold.

Hutchin Hill Capital first reported a position in EHC in Q2 2013 and held it in 8 quarters. The position peaked at $4.03M in Q4 2015. 333 funds tracked by Wall St. Rank hold EHC as of Q2 2017.

  • Hutchin Hill Capital reported no remaining Encompass Health position as of Q2 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 14,581 Encompass Health shares in Q2 2017, an estimated $497K.
  • Hutchin Hill Capital first reported a position in Encompass Health in Q2 2013 and held it in 8 quarters.
  • Hutchin Hill Capital's Encompass Health position peaked at $4.03M in Q4 2015.
  • 333 funds tracked by Wall St. Rank held Encompass Health as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.